Share

February 2018; 8 (1) Research

Pilot study of volume contracted state and hospital outcome after stroke

Mona N. Bahouth, Andrew Gaddis, Argye E. Hillis, Rebecca F. Gottesman
First published January 22, 2018, DOI: https://doi.org/10.1212/CPJ.0000000000000419
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
50

Share

Article Information

vol. 8 no. 1 21-26
DOI: 
https://doi.org/10.1212/CPJ.0000000000000419
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received June 14, 2017
  • Accepted August 22, 2017
  • First Published January 22, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Mona N. Bahouth, MD,
    2. Andrew Gaddis, MHS,
    3. Argye E. Hillis, MD and
    4. Rebecca F. Gottesman, MD, PhD
  1. Mona N. Bahouth, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Johns Hopkins School of Medicine, Richard Starr Ross Clinician a Scientist Award

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Andrew Gaddis, MHS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Argye E. Hillis, MD and
    4. Scientific Advisory Boards:

    1. Paid member of Data Safety Monitoring Board for Axovant

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Stroke, Associate Editor, 2014-present; Aphasiology, Associate Editor, 2008-present, Practice Update Neurology, Associate Editor, 2015-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. Handbook of Adult Language Disorders, Taylor & Francis, 2015

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. The Charles Dana Foundation

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIDCD RO1 DC05375 2008-current, PI (2) P50 DC014664, PI of project 2 and PI of clinical core, 2016-current (3)NIDCD, R01DC015466, PI, 2017-2023 (4)NINDS, R25, PI, 2009-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Rebecca F. Gottesman, MD, PhD
    5. Scientific Advisory Boards:

    1. Member of DSMB for "Sail-on" study, (PI: V. Urrutia), funded via Genentech (no compensation received).

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Cardiothoracic Surgery Symposium; funds for travel (reimbursement)

    Editorial Boards:

    1. Neurology, Associate Editor, 2015-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Florbetapir isotope (18F-AV-45) provided for investigator-initiated research by Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly.

    Research Support, Government Entities:

    1. National Institutes of Health/ National Institute on Aging. 1R01AG040282, Principal Investigator, 9/2011-8/2021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
  1. Correspondence
    Dr. Bahouth mbahout1{at}jhmi.edu
View Full Text

Article usage

Article usage: January 2018 to December 2021

AbstractFullPdfSource
Jan 20185005Highwire
Feb 20183173712Highwire
Mar 2018529185Highwire
Apr 201814842Highwire
May 20187613Highwire
Jun 20186131Highwire
Jul 20188703Highwire
Aug 20183601Highwire
Sep 20183601Highwire
Oct 20184102Highwire
Nov 20186122Highwire
Dec 20187600Highwire
Jan 20196711Highwire
Feb 20196620Highwire
Mar 20193300Highwire
Apr 20193302Highwire
May 20192610Highwire
Jun 20192100Highwire
Jul 20193011Highwire
Aug 20192100Highwire
Sep 20191200Highwire
Oct 20191112Highwire
Nov 20191100Highwire
Dec 2019900Highwire
Jan 20201600Highwire
Feb 20201700Highwire
Mar 20201500Highwire
Apr 2020200Highwire
May 20202400Highwire
Jun 20201000Highwire
Jul 2020800Highwire
Aug 2020800Highwire
Sep 20202300Highwire
Oct 20203411Highwire
Nov 20202000Highwire
Dec 20204500Highwire
Jan 2021602Highwire
Feb 20211800Highwire
Mar 20211100Highwire
Apr 2021500Highwire
May 20213202Highwire
Jun 20211200Highwire
Jul 20213000Highwire
Aug 20213700Highwire
Sep 20212311Highwire
Oct 20212800Highwire
Nov 2021700Highwire
Dec 20212321Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me